Pediatric cerebellar mutism syndrome after posterior fossa tumor surgery: a single-center experience

Purpose The study aims to characterize pediatric cerebellar mutism syndrome (CMS) following posterior fossa tumor surgery, with particular attention to its incidence, clinical course, associated factors, and management. Methods We retrospectively reviewed children aged 3–17 years who underwent posterior fossa tumor resection at a single pediatric neurosurgical center between 2015 and 2025. CMS ascertainment was restricted to postoperative complete mutism. Demographic, clinical, tumor-related, and operative characteristics were compared between children with and without CMS, and management of affected patients was reviewed. Results Among 150 patients, 10 developed CMS (6.7%). Median onset was 1 day after surgery, and median duration of mutism was 41 days. All children with CMS had fourth ventricular tumor involvement. Medulloblastoma (60.0% vs 23.6%; p = 0.020) and urgent surgery (90.0% vs 56.4%; p = 0.047) were more frequent among affected children. The telovelar route was the standard approach to fourth ventricular tumors at our institution (90.9%). Among patients with fourth ventricular tumors treated via the telovelar or transvermian route, CMS occurred in 15.0% and 16.7%, respectively (p = 1.000). Extent of resection did not differ significantly (p = 0.543). Seven children with CMS received pharmacological treatment, most commonly sertraline or benzodiazepines. Conclusions In our institutional experience, CMS occurred in 6.7% of patients and was observed exclusively in children with fourth ventricular involvement. Medulloblastoma and urgent surgery were more frequent among affected patients, although independent effects could not be established. Treatment was individualized, precluding conclusions regarding efficacy.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-20
DOI
https://doi.org/10.21203/rs.3.rs-11200298/v1
Primary Topic
Glioma Diagnosis and Treatment
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Pediatric cerebellar mutism syndrome after posterior fossa tumor surgery: a single-center experience

Marek Mandera, Ryszard Sordyl, Karolina Sztuba, Natalia Kardas et al.
Research Square
Glioma Diagnosis and Treatment
preprint

Pediatric cerebellar mutism syndrome after posterior fossa tumor surgery: a single-center experience

Marek Mandera, Ryszard Sordyl, Karolina Sztuba, Natalia Kardas, Natalia Wyroba
preprint en

Abstract

Purpose The study aims to characterize pediatric cerebellar mutism syndrome (CMS) following posterior fossa tumor surgery, with particular attention to its incidence, clinical course, associated factors, and management. Methods We retrospectively reviewed children aged 3–17 years who underwent posterior fossa tumor resection at a single pediatric neurosurgical center between 2015 and 2025. CMS ascertainment was restricted to postoperative complete mutism. Demographic, clinical, tumor-related, and operative characteristics were compared between children with and without CMS, and management of affected patients was reviewed. Results Among 150 patients, 10 developed CMS (6.7%). Median onset was 1 day after surgery, and median duration of mutism was 41 days. All children with CMS had fourth ventricular tumor involvement. Medulloblastoma (60.0% vs 23.6%; p = 0.020) and urgent surgery (90.0% vs 56.4%; p = 0.047) were more frequent among affected children. The telovelar route was the standard approach to fourth ventricular tumors at our institution (90.9%). Among patients with fourth ventricular tumors treated via the telovelar or transvermian route, CMS occurred in 15.0% and 16.7%, respectively (p = 1.000). Extent of resection did not differ significantly (p = 0.543). Seven children with CMS received pharmacological treatment, most commonly sertraline or benzodiazepines. Conclusions In our institutional experience, CMS occurred in 6.7% of patients and was observed exclusively in children with fourth ventricular involvement. Medulloblastoma and urgent surgery were more frequent among affected patients, although independent effects could not be established. Treatment was individualized, precluding conclusions regarding efficacy.

Research Square
Medical University of Silesia (PL)
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon